NRP1 as multifunctional non-tyrosine-kinase receptors play critical roles in tumor progression. MicroRNAs (miRNAs) are an important class of pervasive genes that are involved in a variety of biological functions, particularly cancer. It remains unclear whether miRNAs can regulate the expression of NRP1. The goal of this study was to identify miRNAs that could inhibit the growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. We found that miR-338 expression was reduced in gastric cancer cell lines and in gastric cancer tissues. Moreover, we found that miR-338 inhibited gastric cancer cell migration, invasion, proliferation and promoted apoptosis by targeting NRP1 expression. As an upstream regulator of NRP1, miR-338 directly targets NRP1. The forced expression of miR-338 inhibited the phosphorylation of Erk1/2, P38 MAPK and Akt; however, the expression of phosphorylated Erk1/2, P38 MAPK and Akt was restored by the overexpression of NRP1. In AGS cells infected with miR-338 or transfected with SiNRP1, the protein levels of fibronectin, vimentin, N-cadherin and SNAIL were decreased, but the expression of E-cadherin was increased. The expression of mesenchymal markers in miR-338-expressing cells was restored to normal levels by the restoration of NRP1 expression. In vivo, miR-338 also decreased tumor growth and suppressed D-MVA by targeting NRP1. Therefore, we conclude that miR-338 acts as a novel tumor suppressor gene in gastric cancer. miR-338 can decrease migratory, invasive, proliferative and apoptotic behaviors, as well as gastric cancer EMT, by attenuating the expression of NRP1.
References
[1]
He Z, Tessier-Lavigne M (1997) Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90: 739–751. doi: 10.1016/s0092-8674(00)80534-6
[2]
Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G (2000) Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]. J Biol Chem 275: 18040–18045. doi: 10.1074/jbc.m909259199
[3]
Staton CA, Koay I, Wu JM, Hoh L, Reed MW, et al. (2013) Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer. Histopathology 62: 908–915. doi: 10.1111/his.12098
[4]
Soker S, Fidder H, Neufeld G, Klagsbrun M (1996) Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J Biol Chem 271: 5761–5767. doi: 10.1074/jbc.271.10.5761
[5]
Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735–745. doi: 10.1016/s0092-8674(00)81402-6
[6]
Broholm H, Laursen H (2004) Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors. APMIS 112: 257–263. doi: 10.1111/j.1600-0463.2004.apm11204-0505.x
[7]
Salikhova A, Wang L, Lanahan AA, Liu M, Simons M, et al. (2008) Vascular endothelial growth factor and semaphorin induce neuropilin-1 endocytosis via separate pathways. Circ Res 103: e71–79. doi: 10.1161/circresaha.108.183327
[8]
Wang L, Zeng H, Wang P, Soker S, Mukhopadhyay D (2003) Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem 278: 48848–48860. doi: 10.1074/jbc.m310047200
[9]
Murga M, Fernandez-Capetillo O, Tosato G (2005) Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood 105: 1992–1999. doi: 10.1182/blood-2004-07-2598
[10]
Glinka Y, Stoilova S, Mohammed N, Prud'homme GJ (2011) Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis 32: 613–621. doi: 10.1093/carcin/bgq281
[11]
Pellet-Many C, Frankel P, Evans IM, Herzog B, Junemann-Ramirez M, et al. (2011) Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas. Biochem J 435: 609–618. doi: 10.1042/bj20100580
[12]
Rossignol M, Pouyssegur J, Klagsbrun M (2003) Characterization of the neuropilin-1 promoter; gene expression is mediated by the transcription factor Sp1. J Cell Biochem 88: 744–757. doi: 10.1002/jcb.10384
[13]
Yu DC, Waby JS, Chirakkal H, Staton CA, Corfe BM (2010) Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation. Mol Cancer 9: 276. doi: 10.1186/1476-4598-9-276
[14]
Rana TM (2007) Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 8: 23–36. doi: 10.1038/nrm2085
[15]
Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515–524. doi: 10.1101/gad.1399806
[16]
Pillai RS, Bhattacharyya SN, Filipowicz W (2007) Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17: 118–126. doi: 10.1016/j.tcb.2006.12.007
[17]
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834–838. doi: 10.1038/nature03702
[18]
Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, et al. (2006) Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20: 2202–2207. doi: 10.1101/gad.1444406
[19]
Luo H-C, Zhang Z-Z, Zhang X (2009) MicroRNA Expression Signature in Gastric Cancer. Chin J Cancer Res 21: 74–81. doi: 10.1007/s11670-009-0074-z
[20]
Huang XH, Chen JS, Wang Q, Chen XL, Wen L, et al. (2011) miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol 225: 463–472. doi: 10.1002/path.2877
[21]
Caramuta S, Egyhazi S, Rodolfo M, Witten D, Hansson J, et al. (2010) MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 130: 2062–2070. doi: 10.1038/jid.2010.63
[22]
Akagi M, Kawaguchi M, Liu W, McCarty MF, Takeda A, et al. (2003) Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells. Br J Cancer 88: 796–802.
[23]
Wey JS, Gray MJ, Fan F, Belcheva A, McCarty MF, et al. (2005) Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Br J Cancer 93: 233–241.
[24]
Subauste MC, Pertz O, Adamson ED, Turner CE, Junger S, et al. (2004) Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J Cell Biol 165: 371–381. doi: 10.1083/jcb.200308011
[25]
Kong X, Zheng F, Guo LY, Yang JY, Zhang L, et al. (2010) [VEGF promotes the proliferation of bone marrow derived mesenchymal stem cells through ERK1/2 signal pathway]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18: 1292–1296.
[26]
Ruffini F, D'Atri S, Lacal PM (2013) Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms. Int J Oncol 43: 297–306. doi: 10.3892/ijo.2013.1948
[27]
Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593–601. doi: 10.1038/ncb1722
[28]
Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247–256. doi: 10.1038/ncb2024
[29]
Zhang Z, Liu S, Shi R, Zhao G (2011) miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet 204: 486–491. doi: 10.1016/j.cancergen.2011.07.004
[30]
Fuxe J, Vincent T, Garcia de Herreros A (2010) Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 9: 2363–2374. doi: 10.4161/cc.9.12.12050
[31]
Wu YY, Chen YL, Jao YC, Hsieh IS, Chang KC, et al. (2014) miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1. Angiogenesis 17: 247–260. doi: 10.1007/s10456-013-9394-1
[32]
Dallas NA, Gray MJ, Xia L, Fan F, van Buren G 2nd, et al. (2008) Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clin Cancer Res 14: 8052–8060. doi: 10.1158/1078-0432.ccr-08-1520
